Catalyst Funds Management Pty LTD Adicet Bio, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 13,700 shares of ACET stock, worth $15,617. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,700Holding current value
$15,617% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACET
# of Institutions
73Shares Held
59.6MCall Options Held
4.2KPut Options Held
6.7K-
Orbimed Advisors LLC San Diego, CA11.4MShares$13 Million0.39% of portfolio
-
Tang Capital Management LLC San Diego, CA8.22MShares$9.37 Million1.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$8.6 Million0.15% of portfolio
-
Goldman Sachs Group Inc New York, NY3.76MShares$4.29 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$3.65 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $45.6M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...